| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 29,633 | 40,355 | ||
| Short-term investments | 197,883 | 187,136 | ||
| Accounts receivable, net | 24,151 | 28,058 | ||
| Inventories, net | 28,950 | 25,061 | ||
| Prepaid and other current assets | 3,260 | 3,264 | ||
| Total current assets | 283,877 | 283,874 | ||
| Property and equipment, net | 13,096 | 13,255 | ||
| Operating leases right-of-use assets | 10,276 | 10,588 | ||
| Restricted cash | 748 | 750 | ||
| Other assets | 536 | 542 | ||
| Total assets | 308,533 | 309,009 | ||
| Accounts payable | 3,377 | 3,348 | ||
| Accrued expenses and other current liabilities | 17,621 | 15,934 | ||
| Lease liabilities | 1,293 | 1,101 | ||
| Total current liabilities | 22,291 | 20,383 | ||
| Long-term lease liabilities | 10,272 | 10,614 | ||
| Other long-term liabilities | 0 | 0 | ||
| Total liabilities | 32,563 | 30,997 | ||
| Common stock, 0.001 par value, 900,000,000 shares authorized, 41,081,550 shares issued and outstanding as of september 30, 2025 and 40,428,220 shares issued and outstanding as of december 31, 2024 | 41 | 41 | ||
| Additional paid-in capital | 927,756 | 920,159 | ||
| Accumulated other comprehensive income | 60 | -117 | ||
| Accumulated deficit | -651,887 | -642,071 | ||
| Total stockholders' equity | 275,970 | 278,012 | ||
| Total liabilities and stockholders' equity | 308,533 | 309,009 | ||
RxSight, Inc. (RXST)
RxSight, Inc. (RXST)